Alterations in the PI3K pathway drive resistance to MET inhibitors in NSCLC harboring MET exon 14 skipping mutations

Alterations in the PI3K pathway drive resistance to MET inhibitors in NSCLC harboring MET exon 14 skipping mutations. Jamme, Philippe; Fernandes, Marie; Copin, Marie-Christine; Descarpentries, Clotilde; Escande, Fabienne; Morabito, Angela; Grégoire, Valérie; Jamme, Matthieu; Baldacci, Simon; Tulasne, David; Kherrouche, Zoulika; Cortot, Alexis B.. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. 2020; : . doi:10.1016/j.jtho.2020.01.027
Article